GISONDI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 11.376
NA - Nord America 9.831
AS - Asia 7.579
SA - Sud America 1.475
AF - Africa 294
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 30.633
Nazione #
US - Stati Uniti d'America 9.635
RU - Federazione Russa 3.873
SG - Singapore 3.308
GB - Regno Unito 2.025
CN - Cina 1.964
IT - Italia 1.901
BR - Brasile 1.225
HK - Hong Kong 870
IE - Irlanda 643
DE - Germania 620
FR - Francia 619
SE - Svezia 566
VN - Vietnam 505
FI - Finlandia 464
KR - Corea 237
UA - Ucraina 131
ID - Indonesia 119
NL - Olanda 115
TR - Turchia 112
ES - Italia 105
IN - India 104
CA - Canada 91
AR - Argentina 86
JP - Giappone 73
TG - Togo 72
MX - Messico 67
AU - Australia 59
BJ - Benin 58
PL - Polonia 58
AT - Austria 54
EC - Ecuador 51
ZA - Sudafrica 50
BD - Bangladesh 46
CH - Svizzera 30
BE - Belgio 29
IR - Iran 27
CO - Colombia 26
CL - Cile 25
MA - Marocco 24
EG - Egitto 22
SA - Arabia Saudita 22
UZ - Uzbekistan 22
MY - Malesia 19
PY - Paraguay 19
IQ - Iraq 18
KE - Kenya 18
PK - Pakistan 18
CZ - Repubblica Ceca 15
BO - Bolivia 14
DZ - Algeria 13
TN - Tunisia 13
DK - Danimarca 12
PT - Portogallo 12
AL - Albania 11
HR - Croazia 11
IL - Israele 11
RO - Romania 11
KZ - Kazakistan 10
NZ - Nuova Zelanda 10
PH - Filippine 10
UY - Uruguay 10
GR - Grecia 9
HU - Ungheria 9
LT - Lituania 9
VE - Venezuela 9
DO - Repubblica Dominicana 8
PE - Perù 8
TW - Taiwan 8
BG - Bulgaria 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
GE - Georgia 6
IS - Islanda 6
JO - Giordania 6
MM - Myanmar 6
AZ - Azerbaigian 5
BY - Bielorussia 5
EE - Estonia 5
JM - Giamaica 5
NP - Nepal 5
AO - Angola 4
BN - Brunei Darussalam 4
ET - Etiopia 4
GH - Ghana 4
KW - Kuwait 4
LB - Libano 4
LK - Sri Lanka 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
BH - Bahrain 3
EU - Europa 3
GD - Grenada 3
HN - Honduras 3
AG - Antigua e Barbuda 2
CI - Costa d'Avorio 2
GT - Guatemala 2
KG - Kirghizistan 2
LU - Lussemburgo 2
Totale 30.582
Città #
Southend 1.591
Dallas 1.548
Singapore 1.274
Moscow 1.227
Chandler 1.055
Jacksonville 954
Hong Kong 854
Ashburn 778
Dublin 632
Woodbridge 552
Houston 433
Ann Arbor 431
Beijing 351
Wilmington 220
Lawrence 215
Princeton 215
Los Angeles 202
Ho Chi Minh City 192
New York 188
Milan 163
Munich 147
Verona 145
Helsinki 143
Jinan 135
Nanjing 132
Redondo Beach 130
Rome 125
Buffalo 121
Hanoi 114
London 105
São Paulo 104
The Dalles 101
Shenyang 100
Sindelfingen 93
Jakarta 77
Lomé 72
Santa Clara 67
Tianjin 65
Hebei 63
Cotonou 58
Haikou 55
Seattle 55
Changsha 52
Chicago 52
Guangzhou 52
Washington 48
Columbus 46
Bologna 45
Hangzhou 44
Nanchang 44
Tokyo 44
Warsaw 43
Council Bluffs 42
Redwood City 42
Rio de Janeiro 41
Madrid 40
Amsterdam 38
Naples 38
Zhengzhou 38
Lappeenranta 37
Frankfurt am Main 36
Belo Horizonte 35
Boardman 34
Atlanta 33
Jiaxing 33
Brooklyn 32
Phoenix 32
Nuremberg 30
Vienna 30
Falls Church 29
Johannesburg 29
Kent 29
Turin 29
Ningbo 28
Stockholm 28
Brasília 27
Brussels 27
Redmond 27
Toronto 27
Curitiba 26
Venice 26
Esslingen am Neckar 25
Mexico City 25
Montreal 23
Seoul 23
Sydney 23
Taizhou 23
Boston 22
Chennai 22
Fairfield 22
San Francisco 22
Da Nang 21
Florence 21
Genoa 21
Norwalk 21
Shanghai 21
Campinas 20
Haiphong 20
Quito 20
Kuala Lumpur 19
Totale 17.109
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 649
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 416
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 345
A new instrument for the screening of psoriatic arthritis among psoriatic patients 286
Il ruolo della vitamina D nella dermatite atopica 285
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 279
A systematic review of treatments for pityriasis lichenoides 275
Dietary supplements for lipedema 273
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 183
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 174
Advanced Glycation End Products in the Pathogenesis of Psoriasis 171
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 157
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 147
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 147
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 145
Heat urticaria: a revision of published cases with an update on classification and management 145
Polymorphisms, diet and nutrigenomics 143
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 143
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 142
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 142
Acneiform eruption induced by cetuximab 141
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 140
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 140
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 138
Impact of TNF-α antagonists on the quality of life in selected skin diseases 136
Impact of the COVID-19 pandemic on melanoma diagnosis 136
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 135
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 135
Retention rate of systemic drugs in patients with chronic plaque psoriasis 135
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 134
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 134
Incidence of respiratory and allergic symptoms in Italian and immigrant children 133
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 133
Squamous cell carcinoma arising in lupus vulgaris. 132
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 132
Vitamin D levels in patients with psoriasis with or without arthritis 130
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 130
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 130
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 128
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 128
Targeting TNF-a in psoriasis and psoriatic arthritis. 127
Psoriasis, the liver, and the gastrointestinal tract 127
Psoriasis and the metabolic syndrome 126
Aggiornamento sulla terapie biologiche della psoriasi 125
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 125
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 124
Complicanze dell'obesità: la cute 124
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 124
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 123
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 123
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 122
Attitude to treatment of patients with psoriasis attending SPA center 122
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 122
Severe impairment of quality of life in Hailey-Hailey disease. 121
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 121
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 121
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 121
Lebbra lepromatosa. 120
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 119
Image Gallery: Pyoderma gangrenosum of the penis. 118
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 117
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 117
The expectations of patients with psoriasis during an office consultation 116
Gender perspective in the management of psoriasis 116
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 115
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 115
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 113
Diabetes and the Skin 113
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 113
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 113
Psoriasi. Una guida per una migliore gestione del paziente. 112
Effects of secukinumab on serum adipocytokines: preliminary data 112
Systemic therapy of psoriasis in diabetic patients 111
Hyperuricaemia in patients with chronic plaque psoriasis. 111
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 110
Pimecrolimus in dermatology: atopic dermatitis and beyond. 110
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 110
Chronic plaque psoriasis is associated with increased arterial stiffness 110
Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series. 110
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 110
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 109
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 109
The metabolic syndrome in psoriasis 109
Dermatite atopica. 108
Some considerations about the importance of alliance between patients and dermatologists in psoriasis 108
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 107
Targeting tumor necrosis factor a in the therapy of psoriasis. 106
Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study 106
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 106
Usefulness of the Framingham risk score in patients with chronic psoriasis 105
Considerations for Systemic Treatment of Psoriasis in Obese Patients 105
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 105
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 103
Phenotypes of atopic dermatitis 103
The diagnostic and therapeutic challenge of early psoriatic arthritis 103
Vitamin D status in patients with chronic plaque psoriasis 102
PSORIASIS 102
Metabolic comorbidities and psoriasis. 102
Glomerular filtration rate in patients with moderate-to-severe psoriasis. 102
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 101
Totale 14.137
Categoria #
all - tutte 115.739
article - articoli 112.258
book - libri 369
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.112
Totale 231.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021912 0 0 0 0 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20256.581 386 349 230 1.037 360 299 414 308 941 466 582 1.209
2025/20269.987 1.418 925 1.907 2.685 3.052 0 0 0 0 0 0 0
Totale 31.042